Protocol Ledger

NCT04885647 · Phase II · COMPLETED

A Study of YPEG-rhEPO in Patients Suffered From Anemia Due to Chronic Kidney Disease

Interventional Phase II clinical trial protocol NCT04885647 sponsored by Xiamen Amoytop Biotech Co in Gastroenterology, Hepatology, and Renal, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2021-03-12 Enrollment: 60 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT04885647
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)60 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04885647
Protocol FieldVerified Registry Value
NCT IdentifierNCT04885647
Consolidated Lead SponsorXiamen Amoytop Biotech Co
Therapeutic Condition CohortGastroenterology, Hepatology, and Renal
Clinical Trial PhasePhase II
Overall Recruitment StatusCOMPLETED
Registered Enrollment60 participants (ACTUAL)
Registered Start Date2021-03-12
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Gastroenterology, Hepatology, and Renal Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI